Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

ABSTRACT Accurate, highly specific immunoassays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to evaluate seroprevalence. This study investigated the concordance of results across four immunoassays targeting different antigens for sera collected at the beginning of the...

Full description

Bibliographic Details
Main Authors: Cheryl N. Miller, Keri N. Althoff, David J. Schlueter, Hoda Anton-Culver, Qingxia Chen, Shawn Garbett, Francis Ratsimbazafy, Isaac Thomsen, Elizabeth W. Karlson, Mine Cicek, Ligia A. Pinto, Bradley A. Malin, Lucila Ohno-Machado, Carolyn Williams, David Goldstein, Aymone Kouame, Andrea Ramirez, Kelly A. Gebo, Sheri D. Schully
Format: Article
Language:English
Published: American Society for Microbiology 2022-10-01
Series:mSphere
Subjects:
SARS-CoV-2
IgG antibodies
spike protein
nucleocapsid protein
low prevalence
Online Access:https://journals.asm.org/doi/10.1128/msphere.00257-22

Internet

https://journals.asm.org/doi/10.1128/msphere.00257-22

Similar Items